IDXX · Earnings call · 2026Q2T · Full report

Acquisition / Partnership / Divestiture

IDEXX LABORATORIES INC /DE · 2026-08-04 · Importance 21 · Surprise 24

Management said organic growth remains IDEXX's core investment priority, while business development is being assessed opportunistically. The company is focused on potential assets in diagnostics and software, noting that more recent opportunities have been concentrated in software. IDEXX is willing to deploy excess capital toward business-development opportunities or in-licensing targets, while continuing to use share buybacks as its preferred method of returning excess cash to shareholders.

Key facts

• We have active assessments associated with things outside of our 4 walls and business development continues to be an area that we look at opportunistically as we see assets that may make sense for us.
• We are willing to leverage our capital against business development type of opportunities or in-licensing types of targets as well.